Oppenheimer: The AtriCure (ATRC.US) rating was raised from Perform to be superior to the market rating. The target price was $32.00.
奥本海默：上调AtriCure(ATRC.US)评级，由Perform调整至优于大市评级, 目标价32.00美元。
Oppenheimer: The AtriCure (ATRC.US) rating was raised from Perform to be superior to the market rating. The target price was $32.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.